ArticleJournal of cosmetic dermatology2025
Exposure Data of Cosmetic Products for Patients Undergoing Cancer Treatment.
Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-oncologic skin health: cutaneous recovery and rehabilitation after cancer treatments.Frontiers in oncology · 2026Review
- Exposure Data of Cosmetic Products for Patients Undergoing Cancer Treatment.Journal of cosmetic dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDermo-cosmetics play a major role in the management of cutaneous side effects due to cancer treatments. Before marketing cosmetic products, a safety assessment using realistic exposure data must be performed. However, limited data are available for patients undergoing cancer treatments.
aimsTo obtain information about consumption habits and cosmetic product quantities applied by this specific population.
methods196 participants, between 31 and 86 years old, who have had cancer, were recruited to compose a skincare (N = 150) and a makeup panel (N = 46). Participants completed a questionnaire inquiring about their cancer, treatments, and associated side effects. Frequencies of use of 31 cosmetic and 11 makeup products during and after treatment and changes in consumer behavior were collected. Quantities of five skincare and 10 makeup products were obtained, respectively, through a one-week consumption follow-up and a makeup workshop.
results88% of the panel have had breast cancer and 98% reported at least one cutaneous side effect due to their oncological treatment. More than 80% of the participants have modified their cosmetic consumption since the beginning of their treatment. For 22 products, statistically significant differences between frequency of use during treatment and post-treatment were highlighted. Differences between quantities from this study and already published data were emphasized. For example, participants applied a higher quantity of body balm than the general population.
conclusionThis study provides information on cosmetic consumption habits and quantity data for patients undergoing cancer treatment. These results will allow a more specific exposure and safety assessment for this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.